Search research articles
Contact Us
Filters
Showing results (51-60 of 87) with videos related to
Page
of 9
Sort By:
Cancer
|
November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Pierre Giglio, Megha Dhamne, Kenneth R Hess, et al.
Nature Communications
|
February 23, 2024
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
Alexandre Carpentier, Roger Stupp, Adam M Sonabend, et al.
Plos One
|
March 12, 2014
Molecular subtypes of glioblastoma are relevant to lower grade glioma
Xiaowei Guan, Jaime Vengoechea, Siyuan Zheng, et al.
Cells
|
November 27, 2019
Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [<sup>18</sup>F]FAZA PET <i>In Vivo</i>
Seth T Gammon, Federica Pisaneschi, Madhavi L Bandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials
Funda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
Neuro-Oncology Practice
|
March 9, 2026
Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study
Christina Weyer-Jamora, Melissa S Brie, Paige M Bracci, et al.
Nature Medicine
|
December 25, 2019
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
Sangeeta Goswami, Thomas Walle, Andrew E Cornish, et al.
Journal of Neuro-Oncology
|
January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
Lakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
CNS Oncology
|
May 16, 2022
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
John de Groot, Martina Ott, Jun Wei, et al.
JCO Precision Oncology
|
September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 87) with videos related to
Sort By:
Page
of 9
Cancer
|
November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Pierre Giglio, Megha Dhamne, Kenneth R Hess, et al.
Nature Communications
|
February 23, 2024
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
Alexandre Carpentier, Roger Stupp, Adam M Sonabend, et al.
Plos One
|
March 12, 2014
Molecular subtypes of glioblastoma are relevant to lower grade glioma
Xiaowei Guan, Jaime Vengoechea, Siyuan Zheng, et al.
Cells
|
November 27, 2019
Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [<sup>18</sup>F]FAZA PET <i>In Vivo</i>
Seth T Gammon, Federica Pisaneschi, Madhavi L Bandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials
Funda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
Neuro-Oncology Practice
|
March 9, 2026
Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study
Christina Weyer-Jamora, Melissa S Brie, Paige M Bracci, et al.
Nature Medicine
|
December 25, 2019
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
Sangeeta Goswami, Thomas Walle, Andrew E Cornish, et al.
Journal of Neuro-Oncology
|
January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas
Lakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
CNS Oncology
|
May 16, 2022
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
John de Groot, Martina Ott, Jun Wei, et al.
JCO Precision Oncology
|
September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Page
of 9